Cardiac Consult: A Cleveland Clinic Podcast for Healthcare Professionals

Dr. Nicholas Smedira leads a panel of experts in the discussion of chronic thromboembolic pulmonary hypertension (CTEPH). Cardiac surgeon Dr. Michael Tong, pulmonologist Dr. Gustavo Heresi, interventional radiologist Dr. Ihab Haddadin, and vascular medicine specialist Dr. John Bartholomew provide insight into topics clinicians need to know to manage patients with CTEPH: diagnosis of pulmonary emboli vs. CTEPH, diagnostic imaging, management of acute vs. subacute emboli, patients at risk, surgery techniques vs. interventional approaches and postoperative care .

Kate Patton, Med, RD, CCSD, LD, Preventive Cardiology and athlete nutrition expert from our Sports Cardiology Center discusses the impact of supplements and energy drinks on cardiovascular health and athletic performance and foods that provide sports performance benefits.

Cardiologist Dr. Tamanna Singh from our Sports Cardiology Center discusses diet and nutrition for optimal athletic performance, including nutritional sources, diet types and balancing nutrition for performance with nutrition for cardiovascular health as part of our Sports Cardiology Lecture Series.

Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center introduces pericarditis cases, a discussion of various types of pericarditis including presentation, imaging, pathology, treatment and considerations. Robert Montgomery, MD, Cardiovascular Medicine Fellow presents a case of advanced pericardial constriction. Dr. Paul Cremer moderates a panel including cardiac surgeon Shinya Unai, MD, cardiologists and imaging specialists Dr. Christine Jellis and Dr. Deborah Kwon, and pathologist Dr. Carmela Tan addressing surgical treatment, and advanced imaging.

Dr. Deborah Kwon Director of MRI in the Miller Family Heart & Vascular Institute at Cleveland Clinic answers questions about cardiac MRI: what is the best use? When should contrast be ordered? What is the latest research involving cardiac MRI? And - what clinicians should know about ordering MRI.

Dr. Allan Klein, Director of the Cleveland Clinic Pericardial Disease Center introduces pericarditis cases, a discussion of various types of pericarditis including presentation, imaging, pathology, treatment and considerations. Jay Ramchand, MD, Cardiovascular Medicine Fellow presents two cases of transient pericarditis. Dr. Paul Cremer moderates a panel including cardiac surgeon Shinya Unai, MD, cardiologists and imaging specialists Dr. Christine Jellis and Dr. Deborah Kwon, and pathologist Dr. Carmela Tan addressing surgical treatment, and advanced imaging.

Mazen Hanna, MD, Co-Director of the Cleveland Clinic’s Amyloidosis Center talks about the FDA’s recent approval of the drug Tafamidis for the treatment of ATTR Amyloidosis (also known as Amyloid Transthyretin Amyloidosis), the research behind it, what this medication does, and what this means for patients.

Richard Grimm, DO, Director of the Echocardiography Laboratory, and Helga Lombardo, RDCS, FASE Supervisor, Echocardiography Lab, discuss many aspects of running a successful high volume echo lab.

Dr. Milind Desai, Medical Director of the Aorta Center, discusses a recently published paper looking at a series of asymptomatic middle aged males who underwent chest computed tomographyalong with coronary artery calcium scoring as part of a comprehensive primary prevention evaluation. About 16% had a dilated aortic root when indexed to height. Dr. Desai discusses the implications of these findings. Study can be reviewed in Circulation. 2018;139:557–558

A. Michael Lincoff, MD, Director of the Cleveland Clinic Coordinating Center for Clinical Research (C5Research), reviews the results from clinical trials presented at the 2019 American College of Cardiology Conference focusing on three major practice areas: 1) the use of transcatheter aortic valves (TAVR) in low risk patients (PARTNER 3, Evolut Low); 2) electrophysiology studies (Apple Heart, WRAP-IT) ; and 3) anti-thrombotic therapies in patients with atrial fibrillation, acute coronary syndrome or percutaneous intervention (AUGUSTUS, GLASSY). Dr. Lincoff summarizes the studies’ design and results, and provides insight into the potential impact on future care of patients based on these outcomes.